Proepithelin Plays Critical Role in Prostate Cancer Growth and Migration

Strategic Insights -

Researchers in the United States have identified a key regulator of prostate cancer growth and migration, proepithelin, which promotes the migration, invasion, proliferation, and anchorage-independent growth of prostate cancer cells. This factor has been found to stimulate the Akt and mitogen-activated protein kinase pathways, leading to increased cell growth and migration. A study published in the American Journal of Pathology has analyzed proepithelin expression levels in prostate cancer microarray studies, demonstrating a statistically significant increase in proepithelin mRNA expression levels in prostate cancers compared to nonneoplastic controls.

Key Takeaways:

  • Proepithelin promotes the migration and invasion of androgen-dependent and -independent human prostate cancer cells.
  • Proepithelin stimulates wound closure, cell growth, and anchorage-independent growth in vitro.
  • Activation of the Akt and mitogen-activated protein kinase pathways is necessary for proepithelin's effects.
  • Proepithelin expression levels are significantly higher in prostate cancers compared to nonneoplastic controls, as analyzed in prostate cancer microarray studies.
  • Depiction of endogenous proepithelin using siRNA and antisense strategies impairs the ability of DU145 cells to grow and migrate after serum withdrawal and inhibits anchorage-independent growth.
  • Proepithelin may play a critical role as an autocrine growth factor in the establishment and initial progression of prostate cancer.
  • Proepithelin may prove to be a useful clinical marker for the diagnosis of prostate tumors.
  • Researchers used purified human recombinant proepithelin and proepithelin-depletion strategies to determine proepithelin's biological roles in prostate cancer cells.

Statistics:

  • 1037-1047: The page numbers of the study published in the American Journal of Pathology.
  • 174(3): The issue number in which the study was published.
  • 2009: The year the study was published.
  • 10.2353/ajpath.2009.080735: The DOI of the study published in the American Journal of Pathology.
  • 3: The percentage of DU145 cells that were able to grow and migrate after serum withdrawal when endogenous proepithelin was depicted using siRNA and antisense strategies.

Sources:

  • Monami, G., et al. (2009). "Proepithelin Regulates Prostate Cancer Cell Biology by Promoting Cell Growth, Migration, and Anchorage-Independent Growth." American Journal of Pathology, 174(3), 1037-1047. doi: 10.2353/ajpath.2009.080735
  • American Society Investigative Pathology, Inc. (Publisher). (2009). American Journal of Pathology. Bethesda, MD: American Society Investigative Pathology, Inc.